Results 21 to 30 of about 255,046 (288)

Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins

Immunological Medicine, 2022
Currently, no standard treatment strategy has been established for immune-mediated necrotizing myopathy (IMNM). Here we present a case of IMNM which was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and ...
Tatsuya Shimada, Misako Higashida-Konishi, Mitsuhiro Akiyama, Satoshi Hama, Keisuke Izumi, Shiro Matsubara, Hisaji Oshima, Yutaka Okano   +7 more
doaj   +1 more source

Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins [PDF]

, 2021
Scleromyxedema is a generalized cutaneous mucinosis that may cause internal damage. This condition is frequently associated with monoclonal gammopathy. However, its physiopathological implications remains uncertain.
Letzelter, Mathilde, Grimaux, Xavier
core   +2 more sources

Intravenous Immunoglobulin

Indian Journal of Dermatology, 2021
Background: Many a times while treating dermatoses conventional therapies are either contraindicated or not effective. Intravenous immunoglobulin (IVIG) is a good alternative available to tide over crises. Method: Over the last 15 years of my practice I have used IVIg in various ...
Sanjeev S Vaishampayan, Surendra Singh Bhati, Radha R Lachhiramani, Shivank Shrivastava, Prateek Jain, Ajay Singh Raghuwanshi   +5 more
openaire   +3 more sources

Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses

Acta Dermato-Venereologica, 2020
Intravenous immunoglobulins are an effective and well-tolerated treatment option for immune dermatological diseases. However, they are primarily used to treat diseases with a severe course and are mostly used off-label.
Roberta Scarpone, Katharina Meier, Kamran Ghoreschi, Margitta Worm   +3 more
doaj   +1 more source

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial [PDF]

, 2023
BACKGROUND: The emergence of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) led to the widespread use of anti-inflammatory treatments in the absence of evidence from randomised controlled trials (RCTs).
Grazioli, S, Trück, J, Schöbi, Nina, Bielicki, Julia A, Andre, MC, Blanchard-Rohner, G, Blanchard-Rohner, Geraldine, Atkinson, Andrew, Vanoni, F, Atkinson, A, Trück, Johannes; https://orcid.org/, Schlapbach, Luregn J, Grazioli, Serge, Buettcher, Michael, Perez, M-H, Koehler, H, Perez, Marie-Helene, Bailey, DGN, Trück, Johannes, Swissped RECOVERY Trial Group, Sanchez, Carlos, Buettcher, M, Sanchez, C, Grazioli, S., Bielicki, JA, Welzel, Tatjana, Schlapbach, L.J., Bailey, Douggl G N, Zimmermann, P, Koehler, H., Schöbi, N., Vanoni, Federica, Koehler, Henrik, Buettcher, M., Schlapbach, LJ, Blanchard Rohner, Géraldine, Andre, M.C., Trück, J., Schöbi, N, Zimmermann, Petra, Vanoni, F., Zimmermann, P., Atkinson, A., Andre, Maya C, Bielicki, J.A., Blanchard-Rohner, G., Welzel, T, Perez, M.H., Sanchez, C., Welzel, T.   +49 more
core   +2 more sources

Intravenous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulins types and preferentially in patients with neurologic disorders: a French national multicenter study

, 2022
supplemental data concerning our study "Intravenous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulins types and preferentially in patients with neurologic disorders: a French national multicenter study" ...
VOLAND, P (via Mendeley Data)
core   +3 more sources

Intravenous immunoglobulins in children with new onset dilated cardiomyopathy [PDF]

, 2017
Background: Dilated cardiomyopathy is a rare but serious disorder in children. No effective diagnostic or treatment tools are readily available. This study aimed to evaluate the efficacy of intravenous immunoglobulins in children with new onset dilated ...
Dalinghaus, Michiel, den Boer, Suzanne L., Wildenbeest, Joanne G., Michiel Dalinghaus, Pajkrt, Dasja, Heidendael, Josephine F., Dasja Pajkrt, Suzanne L. Den Boer, Joanne G. Wildenbeest, Bart Straver, Josephine F. Heidendael, Straver, Bart   +11 more
core   +1 more source

Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia [PDF]

The Korean Journal of Internal Medicine, 2019
Background/Aims Few studies have addressed whether there are differences in clinical efficacy between intravenous methylprednisolone (methyl-Pd) and intravenous immunoglobulin (IVIg) use.
Chul Hee Kim, Yoon Seok Choi, Ji Young Moon, Duck Yong Kim, So Yeon Lee, Hyo Jin Lee, Hwan Jung Yun, Samyong Kim, Deog Yeon Jo, Ik Chan Song   +9 more
doaj   +1 more source

Continuous increase of immunoglobulin therapy in Iceland

Clinical Immunology Communications, 2022
Background: The use of immunoglobulin treatment has been increasing for various indications. The objective of this study was to evaluate clinical use of immunoglobulin therapy in Iceland, estimate off-label usage and describe possible changes in this ...
Valgeir Steinn Runólfsson, Björn Rúnar Lúdvíksson, Rannveig Einarsdóttir, Þórunn Óskarsdóttir, Valtýr Thors, Ásgeir Haraldsson   +5 more
doaj   +1 more source

Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders

Therapeutic Advances in Neurological Disorders, 2015
Objective: Intravenous immunoglobulin administration has long been used in the treatment of autoimmune neuromuscular disorders. Immunoglobulins may be administered by intramuscular, intravenous or subcutaneous routes.
Min-Suk Yoon, Ralf Gold, Antonios Kerasnoudis   +2 more
doaj   +1 more source